These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy. Banerjee S; McCutchan JA; Ances BM; Deutsch R; Riggs PK; Way L; Ellis RJ AIDS; 2011 Jan; 25(2):F1-6. PubMed ID: 21150557 [TBL] [Abstract][Full Text] [Related]
23. Establishment of a rodent model of HIV-associated sensory neuropathy. Keswani SC; Jack C; Zhou C; Höke A J Neurosci; 2006 Oct; 26(40):10299-304. PubMed ID: 17021185 [TBL] [Abstract][Full Text] [Related]
24. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. Simpson DM; Haidich AB; Schifitto G; Yiannoutsos CT; Geraci AP; McArthur JC; Katzenstein DA; AIDS; 2002 Feb; 16(3):407-12. PubMed ID: 11834952 [TBL] [Abstract][Full Text] [Related]
25. Quality of life and self-reported lower extremity function in adults with HIV-related distal sensory polyneuropathy. Galantino ML; Kietrys DM; Parrott JS; Stevens ME; Stevens AM; Condoluci DV Phys Ther; 2014 Oct; 94(10):1455-66. PubMed ID: 24853912 [TBL] [Abstract][Full Text] [Related]
26. [Diseases of the peripheral and visual nervous system during infection with human immunodeficiency virus]. Casanova-Sotolongo P; Casanova-Carrillo P; Casanova-Carrillo C Rev Neurol; 2003 Sep 1-15; 37(5):481-5. PubMed ID: 14533099 [TBL] [Abstract][Full Text] [Related]
28. Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team. Simpson DM; Katzenstein DA; Hughes MD; Hammer SM; Williamson DL; Jiang Q; Pi JT AIDS; 1998 Dec; 12(18):2425-32. PubMed ID: 9875580 [TBL] [Abstract][Full Text] [Related]
29. Painful vasculitic neuropathy in HIV-1 infection: relief of pain with prednisone therapy. Bradley WG; Verma A Neurology; 1996 Dec; 47(6):1446-51. PubMed ID: 8960725 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models. Kamerman PR; Moss PJ; Weber J; Wallace VC; Rice AS; Huang W J Peripher Nerv Syst; 2012 Mar; 17(1):19-31. PubMed ID: 22462664 [TBL] [Abstract][Full Text] [Related]
32. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Morgello S; Estanislao L; Simpson D; Geraci A; DiRocco A; Gerits P; Ryan E; Yakoushina T; Khan S; Mahboob R; Naseer M; Dorfman D; Sharp V; Arch Neurol; 2004 Apr; 61(4):546-51. PubMed ID: 15096404 [TBL] [Abstract][Full Text] [Related]
33. HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Maritz J; Benatar M; Dave JA; Harrison TB; Badri M; Levitt NS; Heckmann JM Muscle Nerve; 2010 May; 41(5):599-606. PubMed ID: 20229576 [TBL] [Abstract][Full Text] [Related]
34. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. Schifitto G; Yiannoutsos CT; Simpson DM; Marra CM; Singer EJ; Kolson DL; Nath A; Berger JR; Navia B; J Neurovirol; 2006 Aug; 12(4):328-31. PubMed ID: 16966223 [TBL] [Abstract][Full Text] [Related]